ALSUntangled #72: Insulin.
Amyotroph Lateral Scler Frontotemporal Degener
; 25(3-4): 416-419, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38018119
ABSTRACT
ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here we review insulin, which has at least one plausible mechanism for slowing ALS progression. However, pre-clinical studies are limited and there have been no trials in PALS yet. Insulin use in patients without a metabolic need may cause very serious and potentially lethal side effects. While further studies to evaluate potential benefits may be warranted, at this time we cannot endorse insulin treatment to slow ALS progression.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Esclerosis Amiotrófica Lateral
Límite:
Humans
Idioma:
En
Revista:
Amyotroph Lateral Scler Frontotemporal Degener
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos